As of June 10, 2025, Exacompta Clairefontaine SA's estimated intrinsic value ranges from $86.83 to $684.76 per share, depending on the valuation methodology applied.
| Valuation Method | Fair Value (USD) | Implied Upside/Downside |
|---|---|---|
| Discounted Cash Flow (10Y) | $86.83 | -11.8% |
| Discounted Cash Flow (5Y) | $87.61 | -11.1% |
| Dividend Discount Model (Multi-Stage) | $97.77 | -0.7% |
| Dividend Discount Model (Stable) | $265.63 | +169.7% |
| Earnings Power Value | $684.76 | +595.2% |
Is Exacompta Clairefontaine SA (EXAC.PA) undervalued or overvalued?
With the current market price at $98.50, the stock appears to be significantly undervalued.
Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate Exacompta Clairefontaine SA's intrinsic value, including:
The cost of capital is a critical factor in valuation models, representing the required return for investors.
| WACC Component | Low | High |
|---|---|---|
| Long-term bond rate | 2.6% | 3.1% |
| Equity market risk premium | 5.2% | 6.2% |
| Adjusted beta | 1.26 | 1.35 |
| Cost of equity | 9.2% | 12.0% |
| Cost of debt | 4.0% | 4.5% |
| Tax rate | 13.8% | 19.6% |
| Debt/Equity ratio | 2.38 | 2.38 |
| After-tax WACC | 5.1% | 6.1% |
Our DCF model projects cash flows over 5-year and 10-year horizons, with the following key assumptions:
| DCF Model | Fair Value | Enterprise Value | % from Terminal Value |
|---|---|---|---|
| 5-Year Growth | $88 | $162M | 84.3% |
| 10-Year Growth | $87 | $161M | 71.1% |
| 5-Year EBITDA | $113 | $191M | 86.7% |
| 10-Year EBITDA | $112 | $189M | 75.4% |
The DDM values a company based on its expected future dividend payments. We used two approaches:
EPV assesses a company's value based on its current normalized earnings power, assuming no growth.
| EPV Component | Value |
|---|---|
| Normalized Earnings | $47M |
| Discount Rate (WACC) | 6.1% - 5.1% |
| Enterprise Value | $766M - $908M |
| Net Debt | $63M |
| Equity Value | $704M - $846M |
| Outstanding Shares | 1M |
| Fair Value | $622 - $747 |
| Selected Fair Value | $684.76 |
| Metric | Value |
|---|---|
| Market Capitalization | $111M |
| Enterprise Value | $174M |
| Trailing P/E | 3.80 |
| Forward P/E | 9.85 |
| Trailing EV/EBITDA | 3.85 |
| Current Dividend Yield | 1636.06% |
| Dividend Growth Rate (5Y) | -21.13% |
| Debt-to-Equity Ratio | 2.38 |
To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:
| Valuation Method | Weight | Weighted Value |
|---|---|---|
| Discounted Cash Flow (10Y) | 30% | $26.05 |
| Discounted Cash Flow (5Y) | 25% | $21.90 |
| Dividend Discount Model (Multi-Stage) | 20% | $19.55 |
| Dividend Discount Model (Stable) | 15% | $39.84 |
| Earnings Power Value | 10% | $68.48 |
| Weighted Average | 100% | $175.82 |
Based on our comprehensive valuation analysis, Exacompta Clairefontaine SA's weighted average intrinsic value is $175.82, which is approximately 78.5% above the current market price of $98.50.
Key investment considerations:
Given these factors, we believe Exacompta Clairefontaine SA is currently significantly undervalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.